ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements
Transgene Biotek has received ROC approval to extend its 36th AGM deadline by three months. The meeting for FY2025-26 will now be held by December 31, 2026.
Transgene Biotek Ltd announced the resignation of M/s Vasavi & Co. as Statutory Auditors, effective immediately. The auditors cited pre-occupation with other assignments as the reason.
Transgene Biotek Ltd reported revenue from operations of ₹0.1 Cr and a net loss of ₹0.4 Cr for Q1 FY27.
Transgene Biotek Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.